Published September 8, 2025 | Version v1
Other Open

Should a systematic neoadjuvant strategy be preferred over upfront surgery for resectable pancreatic adenocarcinoma without metastases?

Authors/Creators

  • 1. Tripdatabase

Description

Neoadjuvant therapy for resectable pancreatic cancer may improve surgical outcomes but has not consistently demonstrated overall survival benefits when compared to upfront surgery.

Files

f494e83d-794b-42e0-86ef-4955d0f56878.pdf

Files (18.5 kB)

Name Size Download all
md5:5fe85ea98813286d1a2b85aa39d3e54f
18.5 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/systematic-neoadjuvant-vs-upfront-surgery-pancreatic-adenocarcinoma-f494e83d-794b-42e0-86ef-4955d0f56878 (URL)